Injection paradigm for administration of botulinum toxins | Patent Publication Number 20190060423

US 20190060423 A1

Patent NumberUS 10729751 B2

Application Number16173664

Filled DateOct 29, 2018

Priority DateMar 13, 2015

Publication DateFeb 28, 2019

Original AssigneeAbbvie Inc.

Current AssigneeAllergan

Inventor/ApplicantsAndrew M. Blumenfeld
Mitchell F. Brin

Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.

Check our Latest Report Purchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.